Deltyba - 50mg
Deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (MDR-TB)
Share Now
| Name | Deltyba |
| Description | The pharmacological mode of action of delamanid involves inhibition of the synthesis of the mycobacterial cell wall components, methoxy-mycolic and keto-mycolic acid. The identified metabolites of delamanid do not show anti-mycobacterial activity. |
| Active Ingredient | Delamanid |
| Indication | Deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability. |
| Strengths | 50mg |
| Business Partner | Otsuka Novel Products GmbH |
| Origin | Germany |
